Event announcement: Synchrony 2020 Online Symposium – Translational Research In Autism - November/December 2020

Autism Treatments – Clinical Research Trials

Autism Treatments – Clinical Research Trials

clinical trials autism research participants

Ongoing UK Clinical Trials for Autism – research studies recruiting participants

The following is a list of research trials currently taking place in the UK and actively recruiting study participants. The studies have been designed to investigate the potential of various medications and interventions to help reduce core autism symptoms, and/or difficulties and symptoms frequently experienced by individuals affected by autism such as anxiety, irritability, impulsive, aggressive and self-harming and other challenging behaviours.

Please note that the studies are not run by Thinking Autism. We can not reply to questions about the studies, the treatments themselves, or your or your child’s eligibility to take part in the trials. If you have any questions about the trials or would like your child/ren or yourself to take part in one of the studies please contact the institutions that are running the trials via the links provided.

Please note: the list is not comprehensive. If your organisation is running a trial and recruiting participants who live in the UK please contact us to have it added to the list. In order to qualify for a listing the aims and objectives of the study need to fall under one or both of the following categories: 1. reducing core symptoms of autism 2. addressing underlying or comorbid biomedical disorders that contribute to symptoms and difficulties experienced by individuals with autism.

The list will be updated on an ongoing basis. Please make sure to come back and refresh the page from time to time, or subscribe to our mailing list to be informed of future additions.

STAR-AIMS: improving social communication skills in children with autism (LONDON & UK)

STAR-AIMS is a new clinical trial investigating if a medication called arbaclofen can help improve social difficulties in children and young people with autism.

Why is the study important?
➢ To date, no medications have been approved to support social function in autism. We want to try and change this with your help.
➢ STAR-AIMS is part of AIMS-2-Trials, the largest ever research project in autism.
➢ AIMS-2-Trials and STAR-AIMS will help increase our understanding of autism and improve outcomes and quality of life for people with autism.

Information on AIMS-2 and arbaclofen

Can you or your child take part?
You must be 5 to 17 years of age and have good verbal skills
Have a confirmed diagnosis of an autism spectrum condition (ASD)
Your parent or caregiver is willing to take part in the study with you
You can visit us at one of our UK research sites for your appointments. We will reimburse your travel expenses and offer you £50 worth of vouchers at the end of the study.

Getting involved
If you think you might be interested in taking part or would like to hear more about the study, please contact your nearest STAR-AIMS team for a chat:

London: King’s College London and SLaM: 0207 848 1520 / 0207 848 5260, STAR-AIMS-2-TRIALS@kcl.ac.uk
Newcastle: Clinical Research Facility, NUTH NHS: 0191 282 0070 (to launch here soon).
Glasgow: Queen Elizabeth University Hospital: 0141 232 7600

Bumetanide for Autism treatment trial (CENTRAL LONDON & UK)

A large European multi-centre Phase III trial is currently taking place in France and several other EU countries, including the UK.

This study is investigating the effectiveness of bumetanide for treating core symptoms of autism. Children and adolescents with a diagnosis of autism or suspected diagnosis, aged 2-17 can participate.

UK centres conducting the trials:

ReCognition Health (several recruitment centres in the UK) – click here for more details and to apply

More details and results of previous bumetanide autism trials

Bumetanide for Autism treatment trial (Colchester, Essex)

A large European multi-centre Phase III trial is currently taking place in France and several other EU countries, including the UK.

This study is investigating the effectiveness of bumetanide for treating core symptoms of autism.

Can your child take part?
Children with a confirmed diagnosis of autism who are aged 2-7 years and living in Colchester can take part.
(If your child does not meet those criteria see below for other UK centres participating in bumetanide trial and recruiting older-age children).

Getting involved
This study is no longer recruiting.

More details and results of previous bumetanide autism trials

Thinking Autism blog – science news & updates

Diuretic drug improves core autism symptoms

Diuretic drug improves core autism symptoms

Double-blind randomized multicenter trial finds bumetanide ameliorates core symptoms of autism.A medical drug normally used to relieve fluid retention has been repurposed as a treatment for the core symptoms of autism. Following on from the promising results of their...

read more
ACTH therapy benefits stuttering and autism

ACTH therapy benefits stuttering and autism

Adrenocorticotropic hormone therapy in patients with nighttime subclinical seizure activity improves their stuttering and autism symptoms ACTH therapy improves core symptoms of autism alongside EEG parameters and sublinical seizures. In a retrospective study a total...

read more
Autistic regression linked to autoimmunity

Autistic regression linked to autoimmunity

Autistic regression is a phenomenon where a previously normally developing child loses developmental milestones and previously acquired language and social skills, and regresses into autism. Symptoms such as fever, vomiting, incessant crying, irritability, changes in sleep patterns and emergence of motor abnormalities are frequently noted around the time of autistic regression…

read more
Autism Action Month: 12-month autism research recap 2018

Autism Action Month: 12-month autism research recap 2018

We chose to call April Autism Action month, in large part because there is plenty of general awareness. Given the skyrocketing rates, it’s difficult to find an adult who doesn’t know a child with autism. However, there ought to be vast improvements when it comes to autism research awareness. With that in mind, below is our quick overview of important autism research (action!) from the past 12 months.

read more

Keep informed - subscribe to our mailing list

We will email you autism-related news and updates. You can unsubscribe at any time.

No social media or google account? Sign up with your email address:

.
DISCLAIMER The purpose of this site is to provide information. No information on this website should be construed as medical advice. Neither article authors, associated charities, nor individual contributors take any responsibility or liability for any decision taken by site visitors as a result of the information contained herein or the external links provided. If you need medical advice, please seek it from a suitably qualified practitioner.

Privacy Policy  |  Terms and Conditions
© 2020 Thinking Autism | All rights reserved | Registered Charity: No. 1113628, Limited Company Registered in England: No. 5594787 | Registered address: International House, 24 Holborn Viaduct, London, EC1A 2BN | Contact tel. 07518131697